Serge Belanger
Stock Analyst at Needham
(4.02)
# 368
Out of 4,829 analysts
344
Total ratings
49.53%
Success rate
10.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Serge Belanger
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PCRX Pacira BioSciences | Maintains: Buy | $32 → $30 | $25.38 | +18.20% | 28 | May 9, 2025 | |
| NAMS NewAmsterdam Pharma Company | Maintains: Buy | $42 → $40 | $19.23 | +108.06% | 8 | May 8, 2025 | |
| EOLS Evolus | Reiterates: Buy | $22 | $9.99 | +120.22% | 15 | May 8, 2025 | |
| VRDN Viridian Therapeutics | Maintains: Buy | $38 → $36 | $12.97 | +177.56% | 16 | May 7, 2025 | |
| CRMD CorMedix | Maintains: Buy | $12 → $15 | $11.35 | +32.16% | 17 | May 7, 2025 | |
| ESPR Esperion Therapeutics | Maintains: Buy | $5 → $4 | $0.79 | +408.78% | 20 | May 7, 2025 | |
| OCUL Ocular Therapeutix | Maintains: Buy | $15 → $14 | $7.33 | +91.00% | 3 | May 6, 2025 | |
| BCRX BioCryst Pharmaceuticals | Maintains: Buy | $15 → $17 | $10.34 | +64.49% | 13 | May 6, 2025 | |
| CYTK Cytokinetics | Reiterates: Buy | $72 | $32.53 | +121.33% | 22 | May 2, 2025 | |
| MLTX MoonLake Immunotherapeutics | Reiterates: Buy | $66 | $39.79 | +65.87% | 12 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $2.10 | +90.48% | 22 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $15.77 | +58.53% | 28 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $23.96 | - | 5 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $46 | $29.96 | +53.54% | 25 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $14.36 | +39.28% | 20 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $0.47 | - | 18 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $0.88 | +356.67% | 14 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $24 | $6.74 | +256.08% | 20 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $28 | $12.33 | +127.09% | 20 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $4.39 | - | 6 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $36.02 | +66.57% | 11 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.43 | - | 1 | Mar 31, 2022 |
Pacira BioSciences
May 9, 2025
Maintains: Buy
Price Target: $32 → $30
Current: $25.38
Upside: +18.20%
NewAmsterdam Pharma Company
May 8, 2025
Maintains: Buy
Price Target: $42 → $40
Current: $19.23
Upside: +108.06%
Evolus
May 8, 2025
Reiterates: Buy
Price Target: $22
Current: $9.99
Upside: +120.22%
Viridian Therapeutics
May 7, 2025
Maintains: Buy
Price Target: $38 → $36
Current: $12.97
Upside: +177.56%
CorMedix
May 7, 2025
Maintains: Buy
Price Target: $12 → $15
Current: $11.35
Upside: +32.16%
Esperion Therapeutics
May 7, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $0.79
Upside: +408.78%
Ocular Therapeutix
May 6, 2025
Maintains: Buy
Price Target: $15 → $14
Current: $7.33
Upside: +91.00%
BioCryst Pharmaceuticals
May 6, 2025
Maintains: Buy
Price Target: $15 → $17
Current: $10.34
Upside: +64.49%
Cytokinetics
May 2, 2025
Reiterates: Buy
Price Target: $72
Current: $32.53
Upside: +121.33%
MoonLake Immunotherapeutics
Apr 30, 2025
Reiterates: Buy
Price Target: $66
Current: $39.79
Upside: +65.87%
Apr 11, 2025
Reiterates: Buy
Price Target: $4
Current: $2.10
Upside: +90.48%
Apr 10, 2025
Reiterates: Buy
Price Target: $25
Current: $15.77
Upside: +58.53%
Apr 10, 2025
Reiterates: Hold
Price Target: n/a
Current: $23.96
Upside: -
Apr 9, 2025
Reiterates: Buy
Price Target: $46
Current: $29.96
Upside: +53.54%
Apr 9, 2025
Reiterates: Buy
Price Target: $20
Current: $14.36
Upside: +39.28%
Apr 9, 2025
Reiterates: Hold
Price Target: n/a
Current: $0.47
Upside: -
Apr 8, 2025
Reiterates: Buy
Price Target: $4
Current: $0.88
Upside: +356.67%
Apr 8, 2025
Reiterates: Buy
Price Target: $24
Current: $6.74
Upside: +256.08%
Apr 8, 2025
Reiterates: Buy
Price Target: $28
Current: $12.33
Upside: +127.09%
Apr 1, 2025
Reiterates: Hold
Price Target: n/a
Current: $4.39
Upside: -
Nov 13, 2024
Reiterates: Buy
Price Target: $60
Current: $36.02
Upside: +66.57%
Mar 31, 2022
Downgrades: Hold
Price Target: n/a
Current: $2.43
Upside: -